TY - JOUR
T1 - Aortic stenosis and transcatheter aortic valve implantation
T2 - Current status and future directions in Korea
AU - Kim, Choongki
AU - Hong, Myeong Ki
N1 - Publisher Copyright:
© 2019 Korean Society of Circulation. All rights reserved.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019
Y1 - 2019
N2 - Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve replacement. Current issues including periprocedural safety, long-term adverse events, hemodynamics and durability associated with TAVI should be also solved for expanding use of TAVI. The review presents current status and future directions of TAVI and discusses perspectives in Korea.
AB - Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve replacement. Current issues including periprocedural safety, long-term adverse events, hemodynamics and durability associated with TAVI should be also solved for expanding use of TAVI. The review presents current status and future directions of TAVI and discusses perspectives in Korea.
UR - http://www.scopus.com/inward/record.url?scp=85071614239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071614239&partnerID=8YFLogxK
U2 - 10.4070/kcj.2019.0044
DO - 10.4070/kcj.2019.0044
M3 - Article
AN - SCOPUS:85071614239
VL - 49
SP - 283
EP - 297
JO - Korean Circulation Journal
JF - Korean Circulation Journal
SN - 1738-5520
IS - 4
ER -